Miguel Marino

Dr. Miguel Marino

orcid

Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 July 2019 in Preventive Medicine
Verified
Journal Article
Closed access
NHNathalie Huguet
Nathalie Huguet
HAHeather Angier
Heather Angier
RRRebecca Rdesinski
Rebecca Rdesinski
MHMegan Hoopes
Megan Hoopes
MMMiguel Marino
Miguel Marino
JDJennifer E. DeVoe
Jennifer E. DeVoe

22 January 2021 in Family Practice
Verified
Journal Article
Open access
PDF file
MMMiguel Marino
Miguel Marino
JLJennifer Lucas
Jennifer Lucas
ELEmile Latour
Emile Latour
JHJohn D Heintzman
John D Heintzman
Missing data are a common occurrence in all study designs used to conduct primary care research (pragmatic randomized trials, observational studies, quality improvement efforts, etc.). We define missing data as values not available to the investigator that would have contributed to the final analysis had they been observed. Examples of missing data include patients lost to follow-up, partially filled-out surveys or incomplete medical records. Missing data can compromise the validity of study findings (e.g. risk for bias increases, subgroups of the population may be underrepresented, loss of information, reduced statistical power, etc.) ( 1–5). Multiple studies have shown that high rates of missing data may negatively impact conclusions in primary care studies ( 6–8).

1 December 2015 in Implementation Science
Verified
Journal Article
Open access
PDF file
DCDeborah J. Cohen
Deborah J. Cohen
BBBijal A. Balasubramanian
Bijal A. Balasubramanian
LGLeah Gordon
Leah Gordon
MMMiguel Marino
Miguel Marino
SOSarah Ono
Sarah Ono
JCJohn Creswell
John Creswell
The Agency for Healthcare Research and Quality (AHRQ) launched the EvidenceNOW Initiative to rapidly disseminate and implement evidence-based cardiovascular disease (CVD) preventive care in smaller primary care practices. AHRQ funded eight grantees (seven regional Cooperatives and one independent national evaluation) to participate in EvidenceNOW. The national evaluation examines quality improvement efforts and outcomes for more than 1500 small primary care practices (restricted to those with fewer than ten physicians per clinic). Examples of external support include practice facilitation, expert consultation, performance feedback, and educational materials and activities. This paper describes the study protocol for the EvidenceNOW national evaluation, which is called Evaluating System Change to Advance Learning and Take Evidence to Scale (ESCALATES). This prospective observational study will examine the portfolio of EvidenceNOW Cooperatives using both qualitative and quantitative data. Qualitative data include: online implementation diaries, observation and interviews at Cooperatives and practices, and systematic assessment of context from the perspective of Cooperative team members. Quantitative data include: practice-level performance on clinical quality measures (aspirin prescribing, blood pressure and cholesterol control, and smoking cessation; ABCS) collected by Cooperatives from electronic health records (EHRs); practice and practice member surveys to assess practice capacity and other organizational and structural characteristics; and systematic tracking of intervention delivery. Quantitative, qualitative, and mixed methods analyses will be conducted to examine how Cooperatives organize to provide external support to practices, to compare effectiveness of the dissemination and implementation approaches they implement, and to examine how regional variations and other organization and contextual factors influence implementation and effectiveness. ESCALATES is a national evaluation of an ambitious large-scale dissemination and implementation effort focused on transforming smaller primary care practices. Insights will help to inform the design of national health care practice extension systems aimed at supporting practice transformation efforts in the USA. NCT02560428 (09/21/15)

28 January 2022 in Journal of General Internal Medicine
Verified
Journal Article
Open access
PDF file
AQAna Quiñones
Ana Quiñones
SVSteele H Valenzuela
Steele H Valenzuela
NHNathalie Huguet
Nathalie Huguet
MUMaria Ukhanova
Maria Ukhanova
MMMiguel Marino
Miguel Marino
JHJohn Heintzman
John Heintzman
Background Multimorbidity (≥ 2 chronic diseases) is associated with greater disability and higher treatment burden, as well as difficulty coordinating self-management tasks for adults with complex multimorbidity patterns. Comparatively little work has focused on assessing multimorbidity patterns among patients seeking care in community health centers (CHCs). Objective To identify and characterize prevalent multimorbidity patterns in a multi-state network of CHCs over a 5-year period. Design A cohort study of the 2014–2019 ADVANCE multi-state CHC clinical data network. We identified the most prevalent multimorbidity combination patterns and assessed the frequency of patterns throughout a 5-year period as well as the demographic characteristics of patient panels by prevalent patterns. Participants The study included data from 838,642 patients aged ≥ 45 years who were seen in 337 CHCs across 22 states between 2014 and 2019. Main measures Prevalent multimorbidity patterns of somatic, mental health, and mental-somatic combinations of 22 chronic diseases based on the U.S. Department of Health and Human Services Multiple Chronic Conditions framework: anxiety, arthritis, asthma, autism, cancer, cardiac arrhythmia, chronic kidney disease (CKD), chronic obstructive pulmonary disease (COPD), congestive heart failure, coronary artery disease, dementia, depression, diabetes, hepatitis, human immunodeficiency virus (HIV), hyperlipidemia, hypertension, osteoporosis, post-traumatic stress disorder (PTSD), schizophrenia, substance use disorder, and stroke. Key results Multimorbidity is common among middle-aged and older patients seen in CHCs: 40% have somatic, 6% have mental health, and 24% have mental-somatic multimorbidity patterns. The most frequently occurring pattern across all years is hyperlipidemia-hypertension. The three most frequent patterns are various iterations of hyperlipidemia, hypertension, and diabetes and are consistent in rank of occurrence across all years. CKD-hyperlipidemia-hypertension and anxiety-depression are both more frequent in later study years. Conclusions CHCs are increasingly seeing more complex multimorbidity patterns over time; these most often involve mental health morbidity and advanced cardiometabolic-renal morbidity.

30 April 2021 in American Journal of Hypertension
Verified
Journal Article
Open access
PDF file
NHNathalie Huguet
Nathalie Huguet
ALAnnie Larson
Annie Larson
HAHeather Angier
Heather Angier
MMMiguel Marino
Miguel Marino
BGBeverly B Green
Beverly B Green
JDJennifer E DeVoe
Jennifer E DeVoe
Background: The Affordable Care Act (ACA) Medicaid expansion improved access to health insurance and health care services. This study assessed whether the rate of patients with undiagnosed hypertension and the rate of patients with hypertension without anti-hypertensive medication decreased post-ACA in community health center (CHC). Methods: We analyzed electronic health record data from 2012 to 2017 for 126,699 CHC patients aged 19–64 years with ≥1 visit pre-ACA and ≥1 post-ACA in 14 Medicaid expansion states. We estimated the prevalence of patients with undiagnosed hypertension (high blood pressure reading without a diagnosis for ≥1 day) and the prevalence of patients with hypertension without anti-hypertensive medication by year and health insurance type (continuously uninsured, continuously insured, gained insurance, and discontinuously insured). We compared the time to diagnosis or to anti-hypertensive medication pre- vs. post-ACA. Results: Overall, 37.3% of patients had undiagnosed hypertension and 27.0% of patients with diagnosed hypertension were without a prescribed anti-hypertensive medication for ≥1 day during the study period. The rate of undiagnosed hypertension decreased from 2012 through 2017. Those who gained insurance had the lowest rates of undiagnosed hypertension (2012: 14.8%; 2017: 6.1%). Patients with hypertension were also more likely to receive anti-hypertension medication during this period, especially uninsured patients who experienced the largest decline (from 47.0% to 8.1%). Post-ACA, among patients with undiagnosed hypertension, time to diagnosis was shorter for those who gained insurance than other insurance types. Conclusions: Those who gained health insurance were appropriately diagnosed with hypertension faster and more frequently post-ACA than those with other insurance types. Clinical trials registration: Trial Number NCT03545763.

1 February 2016 in American Journal of Preventive Medicine
Verified
Journal Article
Closed access
MMMiguel Marino
Miguel Marino
SBSteffani R. Bailey
Steffani R. Bailey
RGRachel Gold
Rachel Gold
MHMegan J. Hoopes
Megan J. Hoopes
JOJean P. O’malley
Jean P. O’malley
JDJennifer E. DeVoe
Jennifer E. DeVoe